Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Tetzner
C. Tetzner
University of Vienna
Medicine
Colorectal cancer
Phases of clinical research
Doxorubicin
Chemotherapy
5
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of advanced colorectal cancer with doxorubicin combined with two potential multidrug-resistance-reversing agents : high-dose oral tamoxifen and dexverapamil
1997
Journal of Cancer Research and Clinical Oncology
Georg Weinländer
Gabriela Kornek
Markus Raderer
Michael Hejna
C. Tetzner
W. Scheithauer
Show All
Source
Cite
Save
Citations (24)
Tolerance of the Novel Chemosensitizer Dexverapamil in Combination with Anthracycline Chemotherapy: a Prospective Toxicity Analysis in Advanced Gastrointestinal Cancer
1995
Onkologie
Markus Raderer
T. Maca
J. Kastner
G. Kornek
G. Weinlaender
M. Hejna
C. Tetzner
W. Scheithauer
Show All
Source
Cite
Save
Citations (1)
Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.
1995
Journal of Cancer Research and Clinical Oncology
Werner Scheithauer
Gabriela Kornek
Markus Raderer
K. Koperna-Mach
C. Müller
J. Karner
J. Kastner
C. Tetzner
Show All
Source
Cite
Save
Citations (6)
D-Verapamil and Adriamycin in the treatment of advanced colorectal cancer
1994
W. Scheithauer
G. Kornek
S. Globitz
Markus Raderer
T. Schenk
Christian Müller
C. Tetzner
Show All
Source
Cite
Save
Citations (0)
Phase II study of D-verapamil and doxorubicin in patients with metastatic colorectal cancer.
1993
European Journal of Cancer
W. Scheithauer
G. Kornek
J. Kastner
Markus Raderer
Gottfried J. Locker
D. Depisch
J. Pidlich
C. Tetzner
Show All
Source
Cite
Save
Citations (12)
1